Vivid Genomics' Seed Round

Vivid Genomics raised a round of funding on September 14, 2018. Investors include Ad Astra Ventures.

Vivid Genomics is a diagnostic company developing non-invasive ways to identify neuro-degenerative disease pathologies, drug response, progression rate and tools to facilitate enrollment in clinical t…

Articles about Vivid Genomics' Seed Round: